The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated×2•Originally published 16 April 2026•Updated 18 April 2026•

1 min read

GE HealthCare and RadNet Expand Global AI Mammography Partnership

Key Facts

1GE HealthCare expanded its collaboration with RadNet’s DeepHealth subsidiary to commercialize AI-powered mammography tools globally.

about 2 months ago

Version History

Version 2about 2 months ago

What changed: Specified 2024 as the partnership's origin year and clarified that the expansion represents a new phase focused on international scaling and specific new application deployments.

Version 1about 2 months ago

What changed: Updated the story to include a 21% increase in cancer detection rates and the addition of second reader workflow capabilities.

GE HealthCare has entered the next phase of its strategic collaboration with RadNet’s subsidiary, DeepHealth, which originally began in 2024, to commercialize AI-powered mammography tools globally. A recent real-world analysis demonstrated that integrating DeepHealth solutions led to a significant 21% increase in breast cancer detection rates. This latest expansion aims to extend solutions internationally and offer new applications within the Breast Suite, including ProFound Pro and second reader workflow capabilities. By embedding these AI solutions into medical imaging, the companies aim to improve clinical outcomes and drive operational efficiency for healthcare providers. This move underscores a commitment to innovation in digital diagnostics and broadens access to advanced screening technologies. The expansion is expected to strengthen the market positioning of both GEHC and RDNT within the high-growth medical technology sector.